Amneal Pharmaceuticals (AMRX) Change in Inventory (2017 - 2026)

Amneal Pharmaceuticals' Change in Inventory history runs 10 years deep, the most recent figure standing at $55.0 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 314.38% year-over-year to $55.0 million; the TTM figure through Mar 2026 stood at $128.7 million (down 2.18% YoY), while the FY2025 annual figure was $87.0 million, down 33.33% from the prior year.
• Change in Inventory was $55.0 million for Q1 2026 at Amneal Pharmaceuticals, up from $20.2 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $55.0 million in Q1 2026 to a low of $11.1 million in Q4 2022.
• Historically, Change in Inventory has averaged $29.5 million across 5 years, with a median of $25.5 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Change in Inventory slumped 61.18% in 2025, then soared 314.38% in 2026.
• A 5-year view of Change in Inventory shows it stood at $11.1 million in 2022, then jumped by 108.58% to $23.1 million in 2023, then jumped by 125.14% to $52.0 million in 2024, then tumbled by 61.18% to $20.2 million in 2025, then surged by 172.34% to $55.0 million in 2026.
• The last three Change in Inventory figures came in at $55.0 million (Q1 2026), $20.2 million (Q4 2025), and $30.8 million (Q3 2025), per Business Quant data.